PFE
Pfizer Inc.
- Revenue, 2025
- $62.6B
- YoY, 2025
- −1.6%
- 5-year CAGR
- +8.5%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $62.6B | −1.6% |
| 2024 | $63.6B | +6.8% |
| 2023 | $59.6B | −41.1% |
| 2022 | $101.2B | +24.5% |
| 2021 | $81.3B | +95.2% |
| 2020 | $41.7B | +1.8% |
| 2019 | $40.9B | +0.2% |
| 2018 | $40.8B | −22.3% |
| 2017 | $52.5B | −0.5% |
| 2016 | $52.8B | — |
| 2013 | $51.6B | −5.6% |
| 2012 | $54.7B | −10.4% |
| 2011 | $61.0B | −6.3% |
| 2010 | $65.2B | +32.3% |
| 2009 | $49.3B | +2.0% |
| 2008 | $48.3B | −0.3% |
| 2007 | $48.4B | — |